ENDRA LIFE SCIENCES INC. Proceeds from Issuance or Sale of Equity
ENDRA LIFE SCIENCES INC. (NDRA) reported Proceeds from Issuance or Sale of Equity of $10.62 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2022-03-30
- ENDRA LIFE SCIENCES INC. proceeds from issuance or sale of equity for the quarter ending 2021-12-31 was $321.07K.
- ENDRA LIFE SCIENCES INC. proceeds from issuance or sale of equity for the quarter ending 2021-09-30 was $496.61K.
- ENDRA LIFE SCIENCES INC. proceeds from issuance or sale of equity for fiscal 2021 was $10.62M, a 496.15% increase from fiscal 2020.
- ENDRA LIFE SCIENCES INC. proceeds from issuance or sale of equity for fiscal 2020 was $1.78M.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|
| 2021-12-31 | $321.07K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $817.68K derived: sum of 2 quarters · filed 2022-03-30 | $10.62M 10-K · filed 2022-03-30 | |
| 2021-09-30 | $496.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $10.29M 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $9.80M 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | $1.78M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |